Analyst Ratings for Atara Biotherapeutics (ATRA)

ATRA Rating Summary

ATRA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ATRA
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $13.67 (+35.7%) * Over Last 12-Mos
Rating Score: 3.1 / 10   Percentile Rank: 27%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/18/2026 Freedom Broker Ilya Zubkov Upgrade Hold
(Sell)
10.00
(4.00)
9.58
(10.07)
5.11% Details
5/8/2026 Canaccord John Newman Upgrade Buy
(Hold)
13.00
(N/A)
5.15
(10.07)
95.53% Details